Introduction: Class III malocclusion affects between 5% and 15% of the entire Brazilian population. Objective: The present study aimed to present a clinical case report of the ortho-surgical treatment of a patient with class III malocclusion, showing the follow-up of the good evolution of the treatment and the improvement of the patient's quality of life. Case Report: The patient EOMO, male and 53 years old, presented class III and on 02/03/2003 the patient submitted the orthodontic documentation. The first phase was the surgical expansion of the maxilla, orthodontic treatment of alignment, and maxillomandibular leveling. The second phase was maxillary advancement and mandible reduction surgery. On 07/31/2003, EOMO decided to undergo orthodontics and the indicated surgeries. Today, after years of treatment and surgeries, EOMO lives well and his appearance has improved 100%, and today he lives with a good quality of life. Final considerations: According to the clinical case presented, the treatment of Class III must be fundamentally based on the diagnosis so that the treatment is installed to correct the compromised structures instead of being compensated in places not affected by this malocclusion, that is, it must The degree of involvement of the maxilla and mandible must be evaluated so that the treatment is directed to that bone base and achieves its objectives and impacts of facial improvement. Redirection of growth in Class III cases is indicated as soon as the anomaly is diagnosed, as the displacement processes that occur in the midface can only be affected with treatment as long as the growth zones can respond to the biomechanical stimulus. Therefore, the younger the Class III patient is treated, the better the facial correction effects will be.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.